Worcester College, Oxford
30 September 2024

ATDBio Oligonucleotide Symposium 2024

The inaugural ATDBio Oligonucleotide Symposium was held in Worcester College, Oxford, with over 80 members of the oligonucleotide community in attendance

On the 24th of September, ATDBio proudly hosted its inaugural Oligonucleotide Symposium at Worcester College, Oxford. The event brought together over 80 attendees from a wide range of disciplines and organisations, both academic and commercial, who were all eager to explore the latest advancements in oligonucleotides and their transformative impact on fields such as diagnostics, therapeutics, and DNA nanotechnology.

Held in the award-winning Sultan Nazrin Shah Centre, the symposium featured six presentations by leaders and innovators in the field of oligonucleotides across a wide range of applications. Professor Tom Brown, founder of ATDBio and leader of the Oxford University Nucleic Acids Group, delivered the keynote on Artificial Nucleic Acid Backbones for Biology and Therapeutics. His talk was followed by Professor Lorna Harries, CTO of Senisca, who discussed how Senisca's technology can reverse signs of cellular ageing and markers of age-related diseases. Dr Adam Cribbs of Caeruleus Genomics then presented on Addressing Errors and Artefacts in Long-Read Single-Cell Sequencing: Challenges and Solutions.

Keynote Speaker, Professor Tom Brown, presenting on Artificial Nucleic Acid Backbones
Keynote Speaker, Professor Tom Brown, presenting on Artificial Nucleic Acid Backbones

After a short break for coffee and cake, the second session began with Dr Mark Chadwick from Nanovery, who shared the company's latest developments in DNA nanotechnology for accurately quantifying nucleic acid sequences. Professor Michael Ladomery then spoke on Targeting the ERG Oncogene with Splice-Switching Oligonucleotides. The final presentation came from Dr Jonathan Bath, who explored the use of DNA as a material for building molecular machines. Several of the speakers were kind enough to highlight the importance of ATDBio's oligonucleotide synthesis to the success of their work, and we value the opportunity to help leaders in the field achieve new breakthroughs through the production of high-quality, bespoke oligonucleotides.

The presentations were followed by a networking and drinks reception, offering attendees the chance to connect with peers, establish new relationships, and catch up with familiar faces within the oligonucleotide community. For the team at ATDBio, it was a valuable opportunity to meet many customers face-to-face for the first time, as well as to meet plenty of new faces and learn more about the innovative ways oligonucleotides are being utilized across different sectors.

A fantastic event with a great selection of speakers! Thanks a lot for organising ATDBio. It was great to get to know our oligo community better and finally be able to put faces to names.

Dr Christine Mordstein
Principal Scientist in RNA Therapeutics R&D

ATDBio extends its thanks to the speakers, attendees, and Worcester College staff for helping make the event a success. We hope that all in attendance had a fantastic afternoon, and look forward to seeing you all at the next symposium.

If you were unable to make it this year and would be interested in attending future events, or if you would be interested in presenting your own work, please reach out to us – we would love to hear from you.

Attendees enjoying the networking and drinks session
Attendees enjoying the networking and drinks session